# Encompass Health Corporation  Share Price Target ‘$81.44’, now 11.9% Upside Potential

- Link: https://www.directorstalkinterviews.com/encompass-health-corporation-share-price-target-81.44-now-11.9-upside-potential/4121142023
- Published: 2024-02-09T14:51:40+00:00
- Author: Charlotte Edwards

**Encompass Health Corporation** which can be found using ticker (EHC) have now 
9 confirmed analysts covering the stock with the consensus suggesting a rating of‘
strong_buy’. The target price High/Low ranges between $85.00 and $77.00 calculating
the average target share price we see $81.44. (at the time of writing). Given that
the stocks previous close was at $72.76 this is indicating there is a potential 
upside of 11.9%. There is a 50 day moving average of $68.40 and the 200 day MA is
$66.40. The total market capitalization for the company now stands at 7.36B. The
stock price is currently at: $73.45 USD

 The potential market cap would be $8,241,044,459 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 20.46, revenue per share of $48.25
and a 7.79% return on assets.

Encompass Health Corporation is a provider of post-acute healthcare service. The
Company manages its operations through its inpatient rehabilitation segment. The
Company is the owner and operator of rehabilitation hospitals. It operates hospitals
in approximately 37 states and Puerto Rico, with concentrations in the eastern half
of the United States and Texas. The Company operates approximately 156 inpatient
rehabilitation hospitals. It provides specialized rehabilitative treatment on an
inpatient basis. The Company’s inpatient rehabilitation hospitals offer specialized
rehabilitative care across an array of diagnoses and deliver comprehensive patient
care services. It also provides rehabilitative care for patients recovering from
injury or illness, using advanced technology and treatments to maximize recovery.
Its hospitals provide a comprehensive interdisciplinary clinical approach to treatment
that leverages technologies and advanced therapies and leads to superior outcomes.

Share on: